{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:12:03Z","timestamp":1780089123640,"version":"3.54.0"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T00:00:00Z","timestamp":1181606400000},"content-version":"vor","delay-in-days":2049,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Congestive Heart Failure"],"published-print":{"date-parts":[[2001,11]]},"abstract":"<jats:p><jats:italic>Angiotensin II is the effector peptide of the renin\u2010angiotensin system and is involved in a wide range of physiologic functions that relate to volume control. In this regard, angiotensin II maintains and regulates salt and water balance, is critically involved in cardiovascular function, and governs thirst. When present in excess, angiotensin II can pathologically influence each of these functions. The role of angiotensin II in controlling sodium balance, in both renal insufficiency states and congestive heart failure, is clearly recognized. Alternatively, it is poorly appreciated that angiotensin II plays an important role in both normal and pathologic thirst states. The latter is a potential problem in both end\u2010stage renal disease and congestive heart failure. Angiotensin\u2010converting enzyme (ACE) inhibitors and angiotensin receptor antagonists (AT<jats:sub>1<\/jats:sub>\u2010RAs) have both been shown to reduce abnormal thirst drive. Whether an ACE inhibitor or an AT<jats:sub>1<\/jats:sub>\u2010RA lessens thirst drive to any significant degree relates to its capacity to penetrate the blood\u2010brain barrier. Head\u2010to\u2010head comparisons of ACE inhibitors and AT<jats:sub>1<\/jats:sub>\u2010RAs, as to their effect on thirst drive, have not been undertaken in a systematic fashion; thus, until otherwise established, the effect of these compounds on thirst should be viewed as a class effect, albeit one that is likely to be dosedependent.<\/jats:italic><\/jats:p>","DOI":"10.1111\/j.1527-5299.2001.00274.x","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T11:12:05Z","timestamp":1181646725000},"page":"325-328","source":"Crossref","is-referenced-by-count":13,"title":["Angiotensin II and Thirst: Therapeutic Considerations"],"prefix":"10.1111","volume":"7","author":[{"given":"Domenic A.","family":"Sica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1976.74"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.33.020182.001311"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198409203111202"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(77)90020-X"},{"issue":"21","key":"e_1_2_5_6_2","first-page":"S27","article-title":"Thirst and the renin\u2010angiotensin system","volume":"32","author":"Mann JF","year":"1987","journal-title":"Kidney Int"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-205-43699A"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0173(92)90018-H"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)01807-7"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.225.10.1236"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000179737"},{"key":"e_1_2_5_12_2","first-page":"R372","article-title":"Plasma angiotensin II: dipsogenic levels and angiotensin\u2010generating capacity of renin","volume":"238","author":"Mann JF","year":"1980","journal-title":"Am J Physiol"},{"key":"e_1_2_5_13_2","first-page":"R229","article-title":"Plasma angiotensin II concentrations and experimentally induced thirst","volume":"240","author":"Johnson AK","year":"1981","journal-title":"Am J Physiol"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.219"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380050072023"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6629.1089"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)81059-6"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000170239"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.36"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000176926"},{"key":"e_1_2_5_21_2","first-page":"564","article-title":"Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia","volume":"128","author":"Leier CV","year":"1994","journal-title":"Am J Cardiol"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410806"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(00)00013-0"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1980.tb09721.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-195303000-00006"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196207052670106"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-6-777"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.73.2.257"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-6-782"},{"key":"e_1_2_5_30_2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinte.1992.00400160022006","article-title":"Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin\u2010converting enzyme inhibitors","volume":"152","author":"Oster JR","year":"1992","journal-title":"Ann Intern Med"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(24)29352-6","article-title":"AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats","volume":"298","author":"Gohlke P","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.37.3.981"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00983-2"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02377-5"}],"container-title":["Congestive Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-5299.2001.00274.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-5299.2001.00274.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T06:21:20Z","timestamp":1737094880000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-5299.2001.00274.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1111\/j.1527-5299.2001.00274.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-5299.2001.00274.x","archive":["Portico"],"relation":{},"ISSN":["1527-5299","1751-7133"],"issn-type":[{"value":"1527-5299","type":"print"},{"value":"1751-7133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}